Impact of renin ‐angiotensin system inhibitors on long‐term clinical outcomes of patients with rheumatic heart disease

ConclusionRenin –angiotensin–aldosterone system inhibitor treatment was significantly associated with decreased risks of mortality, HF rehospitalization, and new-onset AF in RHD patients in median 5.9 year follow-up.

Source: ESC Heart Failure - September 21, 2021 Category: Cardiology Authors: Cheng Liu, Yanxian Lai, Deping Wu, Ruibin Fu, Yanfang Li, Hu Li, Tianwang Guan, Yan Shen Tags: Original Research Article Source Type: research